Back to results
US 2020/0199549 A1Published application
TATk-CDKL5 Fusion Proteins, Compositions, Formulations, And Use Thereof
AssigneeAlma Mater Studiorum - Università di Bologna
InventorsElisabetta Ciani, Franco Laccone
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and formulations containing a TATk-CDKL5 fusion protein. Also disclosed are methods of producing a TATk-CDKL5 fusion protein from vectors containing a TATk-CDKL5 cDNA and methods of transducing cells with the vectors containing a TATk-CDKL5 cDNA and the TATk-CDKL5 fusion protein
Claims17
1-39. (canceled)
A recombinant nucleic acid comprising:
- a CDKL5 nucleic acid sequence, wherein the CDKL5 nucleic acid sequence encodes a CDKL5 polypeptide sequence, wherein the CDKL5 polypeptide sequence comprises SEQ ID NO:
- 2 or SEQ ID NO:
- 16;
- and
- a TATκ nucleic acid sequence, wherein the TATκ nucleic acid sequence encodes a TATκ polypeptide sequence, wherein the TATκ polypeptide sequence has 90% to 100% sequence identity to SEQ ID NO:
- 4 and wherein the TATκ nucleic acid sequence is operatively coupled to the CDKL5 nucleic acid sequence and/or the TATκ polypeptide sequence is operatively coupled to the CDKL5 polypeptide sequence.
3 more elements
Dependencies are inferred from the claim text.